Role of the protein kinase BRAF in the pathogenesis of endometriosis.

about

Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis

P2860

Q57169681-788CD3BF-CBA3-4F8E-8CED-FC687C28D50F Q58129865-6AE90711-A07D-4D0C-88DF-F471B02EB3B5

P2860

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

Item

http://www.wikidata.org/entity/Q39844384

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

@en

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

@nl

type

Item

label

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

@en

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

@nl

prefLabel

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

@en

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

@nl

P1476

Role of the protein kinase BRAF in the pathogenesis of endometriosis

@en

P2093

Christiane Chereau

http://www.w3.org/2001/XMLSchema#string

Frédéric Batteux

http://www.w3.org/2001/XMLSchema#string

Louis Marcellin

http://www.w3.org/2001/XMLSchema#string

Pierre-Alexandre Just

http://www.w3.org/2001/XMLSchema#string

Pietro Santulli

http://www.w3.org/2001/XMLSchema#string

Sandrine Chouzenoux

http://www.w3.org/2001/XMLSchema#string

Veronique Boulard

http://www.w3.org/2001/XMLSchema#string

P2860

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.

Vasculogenesis: a new piece of the endometriosis puzzle

Common tasks in microscopic and ultrastructural image analysis using ImageJ

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

P304

1017-1029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14728222.2016.1180367

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carole Nicco

Claudia Tosti

Charles Chapron

P577

2016-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27087167

http://www.w3.org/2001/XMLSchema#string

P921

endometriosis

pathogenesis

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

about

P2860

P2860

Role of the protein kinase BRAF in the pathogenesis of endometriosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921